Bayer Consumer Health's Future Undecided As Firm Kicks Off Strategic Review

Bayer's new CEO says nothing is off the table when it comes to assessing the future direction of the business. As part of a company-wide strategic review, he and his executive team will decide whether to break up or keep in place Bayer's three pillar structure, comprising Consumer Health, Pharmaceuticals and Crop Science.